While appraising the association between HOXB13-pGly84Glu mutation and colorectal cancer (CRC) patients in two different population registries, 0.48% of the cases had HOXB13 mutation when compared to the control group (0.17%) (Akbari et al. 2013). This evidence concerns the gene HOXB13 and colorectal cancer.